Рејноов феномен (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Рејноов феномен" in Serbian language version.

refsWebsite

Global rank Serbian rank

57doi.org

2^nd place

4^th place

47nih.gov

4^th place

8^th place

11archive.org

6^th place

5^th place

7semanticscholar.org

11^th place

23^rd place

7worldcat.org

5^th place

12^th place

6web.archive.org

1^st place

3medscape.com

719^th place

468^th place

3oxfordjournals.org

1,389^th place

438^th place

2thefreedictionary.com

614^th place

270^th place

2fda.gov

447^th place

925^th place

1myoptumhealth.com

low place

1raynauds.org.uk

low place

1whonamedit.com

2,888^th place

3,693^rd place

1ahajournals.org

3,608^th place

3,815^th place

1wikipedia.org

low place

1handle.net

102^nd place

266^th place

1kardio.hr

low place

1whfreeman.com

low place

422^nd place

1lww.com

2,769^th place

1,062^nd place

1iprshealth.com

low place

1pdfcoffee.com

low place

6,621^st place

ahajournals.org

circ.ahajournals.org

Freedman, R. R.; Baer, R. P.; Mayes, M. D. (1995). „Blockade of vasospastic attacks by alpha 2-adrenergic but not alpha 1-adrenergic antagonists in idiopathic Raynaud's disease”. Circulation. 92 (6): 1448—1451. PMID 7664425. doi:10.1161/01.CIR.92.6.1448.

archive.org

Block, J. A.; Sequeira, W. (2001). „Raynaud's phenomenon”. Lancet. 357 (9273): 2042—8. PMID 11438158. S2CID 27272970. doi:10.1016/S0140-6736(00)05118-7.
Jay, O.; Havenith, G. (2004). „Finger skin cooling on contact with cold materials: A comparison between male and female responses during short-term exposures”. European Journal of Applied Physiology. 91 (4): 373—381. PMID 14605896. S2CID 35852625. doi:10.1007/s00421-003-0986-0. .
Herrick, A. L.; Illingworth, K.; Blann, A.; Hay, C. R.; Hollis, S.; Jayson, M. I. (1996). „Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis”. Annals of the Rheumatic Diseases. 55 (2): 122—7. PMC 1010106 . PMID 8712862. doi:10.1136/ard.55.2.122.
Prescott, R. J.; Freemont, A. J.; Jones, C. J.; Hoyland, J.; Fielding, P. (1992). „Sequential dermal microvascular and perivascular changes in the development of scleroderma”. J Pathol. 166 (3): 255—63. PMID 1517881. S2CID 38077812. doi:10.1002/path.1711660307.
Bunker, C. B.; Goldsmith, P. C.; Leslie, T. A.; Hayes, N.; Foreman, J. C.; Dowd, P. M. (март 1996). „Calcitonin gene-related peptide, endothelin-1, the cutaneous microvasculature and Raynaud's phenomenon”. British Journal of Dermatology. 134 (3): 399—406. PMID 8731660. doi:10.1111/j.1365-2133.1996.tb16221.x (неактивно 8. 12. 2024).
Kahaleh, M. Bashar (1982). „Elevated Levels of Circulating Platelet Aggregates and Beta-Thromboglobulin in Scleroderma”. Annals of Internal Medicine. 96 (5): 610—3. PMID 6176160. doi:10.7326/0003-4819-96-5-610.
Herrick, A. L.; Rieley, F.; Schofield, D.; Hollis, S.; Braganza, J. M.; Jayson, M. I. (1994). „Micronutrient antioxidant status in patients with primary Raynaud's phenomenon and systemic sclerosis”. J Rheumatol. 21 (8): 1477—83. PMID 7983650.
Gross, S.; Tilly, P.; Hentsch, D.; Vonesch, J. L.; Fabre, J. E. (2007). „Vascular wall-produced prostaglandin E2 exacerbates arterial thrombosis and atherothrombosis through platelet EP3 receptors”. Journal of Experimental Medicine. 204 (2): 311—320. PMC 2118736 . PMID 17242161. doi:10.1084/jem.20061617.
Thompson, A. E.; Pope, J. E. (2005). „Calcium channel blockers for primary Raynaud's phenomenon: A meta-analysis”. Rheumatology. 44 (2): 145—50. PMID 15546967. doi:10.1093/rheumatology/keh390.
Agah, R.; Bandi, V.; Guntupalli, K. K. (1997). „Angioedema: The role of ACE inhibitors and factors associated with poor clinical outcome”. Intensive Care Medicine. 23 (7): 793—6. PMID 9290997. S2CID 9530224. doi:10.1007/s001340050413.
Knighton, D. R.; Silver, I. A.; Hunt, T. K. (август 1981). „Regulation of wound-healing angiogenesis-effect of oxygen gradients and inspired oxygen concentration”. Surgery. 90 (2): 262—70. PMID 6166996. .

doi.org

Goundry, B.; Bell, L.; Langtree, M.; Moorthy, A. (2012). „Diagnosis and management of Raynaud's phenomenon”. BMJ. 344: e289. PMID 22315243. S2CID 29237865. doi:10.1136/bmj.e289.
Block, J. A.; Sequeira, W. (2001). „Raynaud's phenomenon”. Lancet. 357 (9273): 2042—8. PMID 11438158. S2CID 27272970. doi:10.1016/S0140-6736(00)05118-7.
Suter, L. G.; Murabito, J. M.; Felson, D. T.; Fraenkel, L. (април 2005). „The incidence and natural history of Raynaud's phenomenon in the community”. Arthritis Rheum. 52 (4): 1259—63. PMID 15818710. doi:10.1002/art.20988. .
Jay, O.; Havenith, G. (2004). „Finger skin cooling on contact with cold materials: A comparison between male and female responses during short-term exposures”. European Journal of Applied Physiology. 91 (4): 373—381. PMID 14605896. S2CID 35852625. doi:10.1007/s00421-003-0986-0. .
Pistorius, M. A.; Planchon, B.; Schott, J. J.; Lemarec, H. (2006). „Heredity and genetic aspects of Raynaud's disease”. Journal des Maladies Vasculaires. 31 (1): 10—15. PMID 16609626. doi:10.1016/s0398-0499(06)76512-x.
Freedman, R. R.; Baer, R. P.; Mayes, M. D. (1995). „Blockade of vasospastic attacks by alpha 2-adrenergic but not alpha 1-adrenergic antagonists in idiopathic Raynaud's disease”. Circulation. 92 (6): 1448—1451. PMID 7664425. doi:10.1161/01.CIR.92.6.1448.
Littleford, R. C.; Khan, F.; Hindley, M. O.; Ho, M.; Belch, J. J. (1997). „Microvascular abnormalities in patients with vibration white finger”. Q J Med. 90 (8): 525—9. PMID 9327031. doi:10.1093/qjmed/90.8.525.
Gayraud, Martine (2007). „Raynaud's phenomenon”. Joint Bone Spine. 74 (1): e1—e8. PMID 17218139. doi:10.1016/j.jbspin.2006.07.002.
Berlin, Alexander L.; Pehr, Kevin (2004). „Coexistence of erythromelalgia and Raynaud's phenomenon”. Journal of the American Academy of Dermatology. 50 (3): 456—460. PMID 14988692. doi:10.1016/S0190-9622(03)02121-2.
Herrick, A. L.; Illingworth, K.; Blann, A.; Hay, C. R.; Hollis, S.; Jayson, M. I. (1996). „Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis”. Annals of the Rheumatic Diseases. 55 (2): 122—7. PMC 1010106 . PMID 8712862. doi:10.1136/ard.55.2.122.
Rajagopalan, Sanjay; Pfenninger, Dana; Kehrer, Christine; Chakrabarti, Anjan; Somers, Emily; Pavlic, Robert; Mukherjee, Debabrata; Brook, Robert; d'Alecy, Louis G.; Kaplan, Mariana J. (2003). „Increased asymmetric dimethylarginine and endothelin 1 levels in secondary Raynaud's phenomenon: Implications for vascular dysfunction and progression of disease”. Arthritis & Rheumatism. 48 (7): 1992—2000. PMID 12847693. doi:10.1002/art.11060. hdl:2027.42/34308.
Kirchengast, M.; Münter, K. (септембар 1999). „Endothelin-1 and endothelin receptor antagonists in cardiovascular remodeling”. Proc Soc Exp Biol Med. 221 (4): 312—25. PMID 10460693. doi:10.1046/j.1525-1373.1999.d01-88.x.
Sakurai, T.; Goto, K. (новембар 1993). „Endothelins. Vascular actions and clinical implications”. Drugs. 46 (5): 795—804. PMID 7507031. doi:10.2165/00003495-199346050-00001.
Duprez, D. A. (јун 2006). „Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: A clinical review”. Journal of Hypertension. 24 (6): 983—91. PMID 16685192. S2CID 3085972. doi:10.1097/01.hjh.0000226182.60321.69.
Kawaguchi, Y.; Takagi, K.; Hara, M.; Fukasawa, C.; Sugiura, T.; Nishimagi, E.; Harigai, M.; Kamatani, N. (јануар 2004). „Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors”. Arthritis Rheum. 50 (1): 216—26. PMID 14730619. doi:10.1002/art.11364.
Dziadzio, M.; Denton, C. P.; Smith, R.; Howell, K.; Blann, A.; Bowers, E.; Black, C. M. (1999). „Losartan therapy for Raynaud's phenomenon and scleroderma: Clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial”. Arthritis Rheum. 42 (12): 2646—55. PMID 10616013. doi:10.1002/1529-0131(199912)42:12<2646::AID-ANR21>3.0.CO;2-T.
Wigley, F. M.; Flavahan, N. A. (новембар 1996). „Raynaud's phenomenon”. Rheum Dis Clin North Am. 22 (4): 765—81. PMID 8923595. doi:10.1016/S0889-857X(05)70300-8.
Bukhari, M.; Herrick, A. L.; Moore, T.; Manning, J.; Jayson, M. I. (1996). „Increased nailfold capillary dimensions in primary Raynaud's phenomenon and systemic sclerosis”. Br J Rheumatol. 35 (11): 1127—31. PMID 8948300. doi:10.1093/rheumatology/35.11.1127.
Campbell, P. M.; Leroy, E. C. (1975). „Pathogenesis of systemic sclerosis: A vascular hypothesis”. Semin Arthritis Rheum. 4 (4): 351—68. PMID 1135634. doi:10.1016/0049-0172(75)90017-7.
Rodnan, G. P.; Myerowitz, R. L.; Justh, G. O. (1980). „Morphologic changes in the digital arteries of patients with progressive systemic sclerosis (Scleroderma) and Raynaud phenomenon”. Medicine. 59 (6): 393—408. PMID 7442530. doi:10.1097/00005792-198011000-00001.
Flavahan, N. A.; Flavahan, S.; Mitra, S.; Chotani, M. A. (2003). „The vasculopathy of Raynaud's phenomenon and scleroderma”. Rheum Dis Clin North Am. 29 (2): 275—91. PMID 12841295. doi:10.1016/S0889-857X(03)00021-8.
Rajkumar, V. S.; Sundberg, C.; Abraham, D. J.; Rubin, K.; Black, C. M. (1999). „Activation of microvascular pericytes in autoimmune Raynaud's phenomenon and systemic sclerosis”. Arthritis Rheum. 42 (5): 930—41. PMID 10323448. doi:10.1002/1529-0131(199905)42:5<930::AID-ANR11>3.0.CO;2-1.
Prescott, R. J.; Freemont, A. J.; Jones, C. J.; Hoyland, J.; Fielding, P. (1992). „Sequential dermal microvascular and perivascular changes in the development of scleroderma”. J Pathol. 166 (3): 255—63. PMID 1517881. S2CID 38077812. doi:10.1002/path.1711660307.
Edwards, Clare M.; Marshall, Janice M.; Pugh, M. (септембар 1998). „Lack of habituation of the pattern of cardiovascular response evoked by sound in subjects with primary Raynaud's disease”. Clin Sci (Lond). 95 (3): 249—60. doi:10.1042/cs0950249. .
Bunker, C. B.; Terenghi, G.; Springall, D. R.; Polak, J. M.; Dowd, P. M. (децембар 1990). „Deficiency of calcitonin gene-related peptide in Raynaud's phenomenon”. Lancet. 336 (8730): 1530—3. PMID 1979366. doi:10.1016/0140-6736(90)93307-B. .
Chotani MA, Flavahan S, Mitra S, Daunt D, Flavahan NA. (2000). „Silent alpha(2C)-adrenergic receptors enable cold-induced vasoconstriction in cutaneous arteries.”. Am J Physiol Heart Circ Physiol. Apr. 278 (4): H1075—83. PMID 10749700. doi:10.1152/ajpheart.2000.278.4.H1075.
Furspan, P. B.; Chatterjee, S.; Freedman, R. R. (мај 2004). „Increased tyrosine phosphorylation mediates the cooling-induced contraction and increased vascular reactivity of Raynaud's disease”. Arthritis Rheum. 50 (5): 1578—85. PMID 15146428. doi:10.1002/art.20214.
Lau, C. S.; McLaren, M.; Saniabadi, A.; Belch, J. J. F. (1993). „Increased Whole Blood Platelet Aggregation in Patients with Raynaud's Phenomenon with or without Systemic Sclerosis”. Scandinavian Journal of Rheumatology. 22 (3): 97—101. PMID 8316776. doi:10.3109/03009749309099251.
Kahaleh, M. Bashar (1982). „Elevated Levels of Circulating Platelet Aggregates and Beta-Thromboglobulin in Scleroderma”. Annals of Internal Medicine. 96 (5): 610—3. PMID 6176160. doi:10.7326/0003-4819-96-5-610.
Herrick AL (мај 2005). „Pathogenesis of Raynaud's phenomenon”. Rheumatology (Oxford). 44 (5): 587—96. PMID 15741200. doi:10.1093/rheumatology/keh552.
Lafferty, K.; De Trafford, J. C.; Potter, C.; Roberts, V. C.; Cotton, L. T. (1985). „Reflex vascular responses in the finger to contralateral thermal stimuli during the normal menstrual cycle: A hormonal basis to Raynaud's phenomenon?”. Clin Sci. 68 (6): 639—45. PMID 2485265. doi:10.1042/cs0680639.
Matucci-Cerinic, M; Allanore, Y; Czirják, L; Tyndall, A; Müller-Ladner, U; Denton, C; Valentini, G; Distler, O; Fligelstone, K (2009-08-12). „The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy”. Annals of the Rheumatic Diseases. 68 (9): 1377—1380. ISSN 0003-4967. doi:10.1136/ard.2008.106302.
Avouac, J; Fransen, J; Walker, UA; Riccieri, V; Smith, V; Muller, C; Miniati, I; Tarner, IH; Randone, S Bellando (2010-11-15). „Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group”. Annals of the Rheumatic Diseases. 70 (3): 476—481. ISSN 0003-4967. doi:10.1136/ard.2010.136929.
Maricq, Hildegard Rand; Carwile LeRoy, E. (1973). „Patterns of finger capillary abnormalities in connective tissue disease by “wide‐field” microscopy”. Arthritis & Rheumatism. 16 (5): 619—628. ISSN 0004-3591. doi:10.1002/art.1780160506.
Cutolo, Maurizio; Sulli, Alberto; Smith, Vanessa (2013). „How to perform and interpret capillaroscopy”. Best Practice & Research Clinical Rheumatology. 27 (2): 237—248. ISSN 1521-6942. doi:10.1016/j.berh.2013.03.001.
Baron, Murray; Bell, Mary; Bookman, Arthur; Buchignani, Maura; Dunne, James; Hudson, Marie; Jerome, Dana; Johnson, Sindhu R.; Jones, Niall (2006-12-09). „Office capillaroscopy in systemic sclerosis”. Clinical Rheumatology. 26 (8): 1268—1274. ISSN 0770-3198. doi:10.1007/s10067-006-0489-6.
Maricq, Hildegard Rand; Carwile LeRoy, E. (1973). „Patterns of finger capillary abnormalities in connective tissue disease by “wide‐field” microscopy”. Arthritis & Rheumatism. 16 (5): 619—628. ISSN 0004-3591. doi:10.1002/art.1780160506.
Maverakis, Emanual; Patel, Forum; Kronenberg, Daniel G.; Chung, Lorinda; Fiorentino, David; Allanore, Yannick; Guiducci, Serena; Hesselstrand, Roger; Hummers, Laura K. (2014). „International consensus criteria for the diagnosis of Raynaud's phenomenon”. Journal of Autoimmunity. 48-49: 60—65. ISSN 0896-8411. doi:10.1016/j.jaut.2014.01.020.
Gross, S.; Tilly, P.; Hentsch, D.; Vonesch, J. L.; Fabre, J. E. (2007). „Vascular wall-produced prostaglandin E2 exacerbates arterial thrombosis and atherothrombosis through platelet EP3 receptors”. Journal of Experimental Medicine. 204 (2): 311—320. PMC 2118736 . PMID 17242161. doi:10.1084/jem.20061617.
Coleiro, B.; Marshall, S. E.; Denton, C. P.; Howell, K.; Blann, A.; Welsh, K. I.; Black, C. M. (2001). „Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine”. Rheumatology. 40 (9): 1038—43. PMID 11561116. doi:10.1093/rheumatology/40.9.1038.
Maddison, P. (2002). „Prevention of vascular damage in scleroderma with angiotensin-converting enzyme (ACE) inhibition”. Rheumatology. 41 (9): 965—71. PMID 12209028. doi:10.1093/rheumatology/41.9.965.
Harrison, B. J.; Silman, A. J.; Hider, S. L.; Herrick, A. L. (2002). „Cigarette smoking as a significant risk factor for digital vascular disease in patients with systemic sclerosis”. Arthritis Rheum. 46 (12): 3312—6. PMID 12483737. doi:10.1002/art.10685.
Cherniack, M.; Clive, J.; Seidner, A. (2000). „Vibration exposure, smoking, and vascular dysfunction”. Occup Environ Med. 57 (5): 341—7. PMC 1739951 . PMID 10769300. doi:10.1136/oem.57.5.341.
Bakst, R.; Merola, J. F.; Franks Jr, A. G.; Sanchez, M. (2008). „Raynaud's phenomenon: Pathogenesis and management”. Journal of the American Academy of Dermatology. 59 (4): 633—53. PMID 18656283. doi:10.1016/j.jaad.2008.06.004.
Thompson, A. E.; Pope, J. E. (2005). „Calcium channel blockers for primary Raynaud's phenomenon: A meta-analysis”. Rheumatology. 44 (2): 145—50. PMID 15546967. doi:10.1093/rheumatology/keh390.
Agah, R.; Bandi, V.; Guntupalli, K. K. (1997). „Angioedema: The role of ACE inhibitors and factors associated with poor clinical outcome”. Intensive Care Medicine. 23 (7): 793—6. PMID 9290997. S2CID 9530224. doi:10.1007/s001340050413.
Vleeming, W.; Van Amsterdam, J. G.; Stricker, B. H.; De Wildt, D. J. (1998). „ACE inhibitor-induced angioedema. Incidence, prevention and management”. Drug Saf. 18 (3): 171—88. PMID 9530537. S2CID 21040028. doi:10.2165/00002018-199818030-00003.
Bakst, R.; Merola, J. F.; Franks Jr, A. G.; Sanchez, M. (2008). „Raynaud's phenomenon: pathogenesis and management”. Journal of the American Academy of Dermatology. 59 (4): 633—53. PMID 18656283. doi:10.1016/j.jaad.2008.06.004.
Sheikh, A. Y.; Gibson, J. J.; Rollins, M. D.; Hopf, H. W.; Hussain, Z.; Hunt, T. K. (новембар 2000). „Effect of hyperoxia on vascular endothelial growth factor levels in a wound model”. Arch Surg. 135 (11): 1293—7. PMID 11074883. doi:10.1001/archsurg.135.11.1293.
Guidot, D. M.; Repine, J. E.; Kitlowski, A. D.; Flores, S. C.; Nelson, S. K.; Wright, R. M.; McCord, J. M. (1995). „Mitochondrial respiration scavenges extramitochondrial superoxide anion via a nonenzymatic mechanism”. Invest. 96 (2): 1131—1136. PMC 185303 . PMID 7635949. doi:10.1172/JCI118100.

dx.doi.org

Matucci-Cerinic, M; Allanore, Y; Czirják, L; Tyndall, A; Müller-Ladner, U; Denton, C; Valentini, G; Distler, O; Fligelstone, K (2009-08-12). „The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy”. Annals of the Rheumatic Diseases. 68 (9): 1377—1380. ISSN 0003-4967. doi:10.1136/ard.2008.106302.
Avouac, J; Fransen, J; Walker, UA; Riccieri, V; Smith, V; Muller, C; Miniati, I; Tarner, IH; Randone, S Bellando (2010-11-15). „Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group”. Annals of the Rheumatic Diseases. 70 (3): 476—481. ISSN 0003-4967. doi:10.1136/ard.2010.136929.
Maricq, Hildegard Rand; Carwile LeRoy, E. (1973). „Patterns of finger capillary abnormalities in connective tissue disease by “wide‐field” microscopy”. Arthritis & Rheumatism. 16 (5): 619—628. ISSN 0004-3591. doi:10.1002/art.1780160506.
Cutolo, Maurizio; Sulli, Alberto; Smith, Vanessa (2013). „How to perform and interpret capillaroscopy”. Best Practice & Research Clinical Rheumatology. 27 (2): 237—248. ISSN 1521-6942. doi:10.1016/j.berh.2013.03.001.
Baron, Murray; Bell, Mary; Bookman, Arthur; Buchignani, Maura; Dunne, James; Hudson, Marie; Jerome, Dana; Johnson, Sindhu R.; Jones, Niall (2006-12-09). „Office capillaroscopy in systemic sclerosis”. Clinical Rheumatology. 26 (8): 1268—1274. ISSN 0770-3198. doi:10.1007/s10067-006-0489-6.
Maricq, Hildegard Rand; Carwile LeRoy, E. (1973). „Patterns of finger capillary abnormalities in connective tissue disease by “wide‐field” microscopy”. Arthritis & Rheumatism. 16 (5): 619—628. ISSN 0004-3591. doi:10.1002/art.1780160506.
Maverakis, Emanual; Patel, Forum; Kronenberg, Daniel G.; Chung, Lorinda; Fiorentino, David; Allanore, Yannick; Guiducci, Serena; Hesselstrand, Roger; Hummers, Laura K. (2014). „International consensus criteria for the diagnosis of Raynaud's phenomenon”. Journal of Autoimmunity. 48-49: 60—65. ISSN 0896-8411. doi:10.1016/j.jaut.2014.01.020.

fda.gov

accessdata.fda.gov

Lubbe, WF, and Hodge, JV: New Zealand Med J, 94 (691) 169–172, 1981. „Minipress Capsules (prazosin hydrochloride) For Oral Use” (PDF). Архивирано из оригинала (PDF) 19. 10. 2011. г. Приступљено 24. 4. 2013.
Davey, DA, and Dommisse, J: S.A. Med J, Oct. 4, 1980 (551–556). „Minipress Capsules (prazosin hydrochloride) For Oral Use” (PDF). Архивирано из оригинала (PDF) 19. 10. 2011. г. Приступљено 24. 4. 2013.

handle.net

hdl.handle.net

Rajagopalan, Sanjay; Pfenninger, Dana; Kehrer, Christine; Chakrabarti, Anjan; Somers, Emily; Pavlic, Robert; Mukherjee, Debabrata; Brook, Robert; d'Alecy, Louis G.; Kaplan, Mariana J. (2003). „Increased asymmetric dimethylarginine and endothelin 1 levels in secondary Raynaud's phenomenon: Implications for vascular dysfunction and progression of disease”. Arthritis & Rheumatism. 48 (7): 1992—2000. PMID 12847693. doi:10.1002/art.11060. hdl:2027.42/34308.

iprshealth.com

„8 Ways to Prevent Raynaud's Syndrome » IPRS Health”. www.iprshealth.com. Приступљено 2024-05-06.

kardio.hr

van Zwieten PA (1994). „Amlodipine: an overview of its pharmacodynamic and pharmacokinetic properties.”. Clin Cardiol. 17 (suppl III): III—3—III—6. . „Terapijski profil amlodipin maleata (Tenox®, Krka)” (PDF). Архивирано из оригинала (PDF) 21. 04. 2016. г. Приступљено 24. 4. 2013.

lww.com

Thomas L. Lemke; David A. Williams, ур. (2002). Foye's Principles of Medicinal Chemistry (5. изд.). Baltimore: Lippincott Willams & Wilkins. стр. 541—4. ISBN 0781744431.

medscape.com

emedicine.medscape.com

Anita Narayanan, Jeffrey R Lisse, Mayra Oberto-Medina, Raynaud Phenomenon-Frequency Jun 3, 2009 http://emedicine.medscape.com/article/331197-overview. Приступљено 24. 4. 2013. Недостаје или је празан параметар |title= (помоћ)
„Raynaud Phenomenon Treatment & Management: Approach Considerations, Nonpharmacologic Therapy, Pharmacologic Therapy”. 4. 8. 2022. Приступљено 24. 4. 2013.
(језик: енглески) „Хипербарична оксигено терапија”. 17. 10. 2021. Приступљено 30. 5. 2009.

myoptumhealth.com

„Raynaud's phenomenon- Definition”. Архивирано из оригинала 03. 04. 2009. г. Приступљено 24. 4. 2013.

nih.gov

ncbi.nlm.nih.gov

Goundry, B.; Bell, L.; Langtree, M.; Moorthy, A. (2012). „Diagnosis and management of Raynaud's phenomenon”. BMJ. 344: e289. PMID 22315243. S2CID 29237865. doi:10.1136/bmj.e289.
Block, J. A.; Sequeira, W. (2001). „Raynaud's phenomenon”. Lancet. 357 (9273): 2042—8. PMID 11438158. S2CID 27272970. doi:10.1016/S0140-6736(00)05118-7.
Suter, L. G.; Murabito, J. M.; Felson, D. T.; Fraenkel, L. (април 2005). „The incidence and natural history of Raynaud's phenomenon in the community”. Arthritis Rheum. 52 (4): 1259—63. PMID 15818710. doi:10.1002/art.20988. .
Jay, O.; Havenith, G. (2004). „Finger skin cooling on contact with cold materials: A comparison between male and female responses during short-term exposures”. European Journal of Applied Physiology. 91 (4): 373—381. PMID 14605896. S2CID 35852625. doi:10.1007/s00421-003-0986-0. .
Pistorius, M. A.; Planchon, B.; Schott, J. J.; Lemarec, H. (2006). „Heredity and genetic aspects of Raynaud's disease”. Journal des Maladies Vasculaires. 31 (1): 10—15. PMID 16609626. doi:10.1016/s0398-0499(06)76512-x.
Freedman, R. R.; Baer, R. P.; Mayes, M. D. (1995). „Blockade of vasospastic attacks by alpha 2-adrenergic but not alpha 1-adrenergic antagonists in idiopathic Raynaud's disease”. Circulation. 92 (6): 1448—1451. PMID 7664425. doi:10.1161/01.CIR.92.6.1448.
Littleford, R. C.; Khan, F.; Hindley, M. O.; Ho, M.; Belch, J. J. (1997). „Microvascular abnormalities in patients with vibration white finger”. Q J Med. 90 (8): 525—9. PMID 9327031. doi:10.1093/qjmed/90.8.525.
Gayraud, Martine (2007). „Raynaud's phenomenon”. Joint Bone Spine. 74 (1): e1—e8. PMID 17218139. doi:10.1016/j.jbspin.2006.07.002.
Berlin, Alexander L.; Pehr, Kevin (2004). „Coexistence of erythromelalgia and Raynaud's phenomenon”. Journal of the American Academy of Dermatology. 50 (3): 456—460. PMID 14988692. doi:10.1016/S0190-9622(03)02121-2.
Herrick, A. L.; Illingworth, K.; Blann, A.; Hay, C. R.; Hollis, S.; Jayson, M. I. (1996). „Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis”. Annals of the Rheumatic Diseases. 55 (2): 122—7. PMC 1010106 . PMID 8712862. doi:10.1136/ard.55.2.122.
Rajagopalan, Sanjay; Pfenninger, Dana; Kehrer, Christine; Chakrabarti, Anjan; Somers, Emily; Pavlic, Robert; Mukherjee, Debabrata; Brook, Robert; d'Alecy, Louis G.; Kaplan, Mariana J. (2003). „Increased asymmetric dimethylarginine and endothelin 1 levels in secondary Raynaud's phenomenon: Implications for vascular dysfunction and progression of disease”. Arthritis & Rheumatism. 48 (7): 1992—2000. PMID 12847693. doi:10.1002/art.11060. hdl:2027.42/34308.
Kirchengast, M.; Münter, K. (септембар 1999). „Endothelin-1 and endothelin receptor antagonists in cardiovascular remodeling”. Proc Soc Exp Biol Med. 221 (4): 312—25. PMID 10460693. doi:10.1046/j.1525-1373.1999.d01-88.x.
Sakurai, T.; Goto, K. (новембар 1993). „Endothelins. Vascular actions and clinical implications”. Drugs. 46 (5): 795—804. PMID 7507031. doi:10.2165/00003495-199346050-00001.
Duprez, D. A. (јун 2006). „Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: A clinical review”. Journal of Hypertension. 24 (6): 983—91. PMID 16685192. S2CID 3085972. doi:10.1097/01.hjh.0000226182.60321.69.
Kawaguchi, Y.; Takagi, K.; Hara, M.; Fukasawa, C.; Sugiura, T.; Nishimagi, E.; Harigai, M.; Kamatani, N. (јануар 2004). „Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors”. Arthritis Rheum. 50 (1): 216—26. PMID 14730619. doi:10.1002/art.11364.
Dziadzio, M.; Denton, C. P.; Smith, R.; Howell, K.; Blann, A.; Bowers, E.; Black, C. M. (1999). „Losartan therapy for Raynaud's phenomenon and scleroderma: Clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial”. Arthritis Rheum. 42 (12): 2646—55. PMID 10616013. doi:10.1002/1529-0131(199912)42:12<2646::AID-ANR21>3.0.CO;2-T.
Wigley, F. M.; Flavahan, N. A. (новембар 1996). „Raynaud's phenomenon”. Rheum Dis Clin North Am. 22 (4): 765—81. PMID 8923595. doi:10.1016/S0889-857X(05)70300-8.
Bukhari, M.; Herrick, A. L.; Moore, T.; Manning, J.; Jayson, M. I. (1996). „Increased nailfold capillary dimensions in primary Raynaud's phenomenon and systemic sclerosis”. Br J Rheumatol. 35 (11): 1127—31. PMID 8948300. doi:10.1093/rheumatology/35.11.1127.
Campbell, P. M.; Leroy, E. C. (1975). „Pathogenesis of systemic sclerosis: A vascular hypothesis”. Semin Arthritis Rheum. 4 (4): 351—68. PMID 1135634. doi:10.1016/0049-0172(75)90017-7.
Rodnan, G. P.; Myerowitz, R. L.; Justh, G. O. (1980). „Morphologic changes in the digital arteries of patients with progressive systemic sclerosis (Scleroderma) and Raynaud phenomenon”. Medicine. 59 (6): 393—408. PMID 7442530. doi:10.1097/00005792-198011000-00001.
Flavahan, N. A.; Flavahan, S.; Mitra, S.; Chotani, M. A. (2003). „The vasculopathy of Raynaud's phenomenon and scleroderma”. Rheum Dis Clin North Am. 29 (2): 275—91. PMID 12841295. doi:10.1016/S0889-857X(03)00021-8.
Rajkumar, V. S.; Sundberg, C.; Abraham, D. J.; Rubin, K.; Black, C. M. (1999). „Activation of microvascular pericytes in autoimmune Raynaud's phenomenon and systemic sclerosis”. Arthritis Rheum. 42 (5): 930—41. PMID 10323448. doi:10.1002/1529-0131(199905)42:5<930::AID-ANR11>3.0.CO;2-1.
Prescott, R. J.; Freemont, A. J.; Jones, C. J.; Hoyland, J.; Fielding, P. (1992). „Sequential dermal microvascular and perivascular changes in the development of scleroderma”. J Pathol. 166 (3): 255—63. PMID 1517881. S2CID 38077812. doi:10.1002/path.1711660307.
Bunker, C. B.; Goldsmith, P. C.; Leslie, T. A.; Hayes, N.; Foreman, J. C.; Dowd, P. M. (март 1996). „Calcitonin gene-related peptide, endothelin-1, the cutaneous microvasculature and Raynaud's phenomenon”. British Journal of Dermatology. 134 (3): 399—406. PMID 8731660. doi:10.1111/j.1365-2133.1996.tb16221.x (неактивно 8. 12. 2024).
Bunker, C. B.; Terenghi, G.; Springall, D. R.; Polak, J. M.; Dowd, P. M. (децембар 1990). „Deficiency of calcitonin gene-related peptide in Raynaud's phenomenon”. Lancet. 336 (8730): 1530—3. PMID 1979366. doi:10.1016/0140-6736(90)93307-B. .
Chotani MA, Flavahan S, Mitra S, Daunt D, Flavahan NA. (2000). „Silent alpha(2C)-adrenergic receptors enable cold-induced vasoconstriction in cutaneous arteries.”. Am J Physiol Heart Circ Physiol. Apr. 278 (4): H1075—83. PMID 10749700. doi:10.1152/ajpheart.2000.278.4.H1075.
Furspan, P. B.; Chatterjee, S.; Freedman, R. R. (мај 2004). „Increased tyrosine phosphorylation mediates the cooling-induced contraction and increased vascular reactivity of Raynaud's disease”. Arthritis Rheum. 50 (5): 1578—85. PMID 15146428. doi:10.1002/art.20214.
Lau, C. S.; McLaren, M.; Saniabadi, A.; Belch, J. J. F. (1993). „Increased Whole Blood Platelet Aggregation in Patients with Raynaud's Phenomenon with or without Systemic Sclerosis”. Scandinavian Journal of Rheumatology. 22 (3): 97—101. PMID 8316776. doi:10.3109/03009749309099251.
Kahaleh, M. Bashar (1982). „Elevated Levels of Circulating Platelet Aggregates and Beta-Thromboglobulin in Scleroderma”. Annals of Internal Medicine. 96 (5): 610—3. PMID 6176160. doi:10.7326/0003-4819-96-5-610.
Herrick AL (мај 2005). „Pathogenesis of Raynaud's phenomenon”. Rheumatology (Oxford). 44 (5): 587—96. PMID 15741200. doi:10.1093/rheumatology/keh552.
Herrick, A. L.; Rieley, F.; Schofield, D.; Hollis, S.; Braganza, J. M.; Jayson, M. I. (1994). „Micronutrient antioxidant status in patients with primary Raynaud's phenomenon and systemic sclerosis”. J Rheumatol. 21 (8): 1477—83. PMID 7983650.
Lafferty, K.; De Trafford, J. C.; Potter, C.; Roberts, V. C.; Cotton, L. T. (1985). „Reflex vascular responses in the finger to contralateral thermal stimuli during the normal menstrual cycle: A hormonal basis to Raynaud's phenomenon?”. Clin Sci. 68 (6): 639—45. PMID 2485265. doi:10.1042/cs0680639.
Gross, S.; Tilly, P.; Hentsch, D.; Vonesch, J. L.; Fabre, J. E. (2007). „Vascular wall-produced prostaglandin E2 exacerbates arterial thrombosis and atherothrombosis through platelet EP3 receptors”. Journal of Experimental Medicine. 204 (2): 311—320. PMC 2118736 . PMID 17242161. doi:10.1084/jem.20061617.
Coleiro, B.; Marshall, S. E.; Denton, C. P.; Howell, K.; Blann, A.; Welsh, K. I.; Black, C. M. (2001). „Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine”. Rheumatology. 40 (9): 1038—43. PMID 11561116. doi:10.1093/rheumatology/40.9.1038.
Van Der Starre, P. J.; Solinas, C. (1996). „Ketanserin in the treatment of protamine-induced pulmonary hypertension”. Tex Heart Inst J. 23 (4): 301—304. PMC 325377 . PMID 8969033.
Maddison, P. (2002). „Prevention of vascular damage in scleroderma with angiotensin-converting enzyme (ACE) inhibition”. Rheumatology. 41 (9): 965—71. PMID 12209028. doi:10.1093/rheumatology/41.9.965.
Harrison, B. J.; Silman, A. J.; Hider, S. L.; Herrick, A. L. (2002). „Cigarette smoking as a significant risk factor for digital vascular disease in patients with systemic sclerosis”. Arthritis Rheum. 46 (12): 3312—6. PMID 12483737. doi:10.1002/art.10685.
Cherniack, M.; Clive, J.; Seidner, A. (2000). „Vibration exposure, smoking, and vascular dysfunction”. Occup Environ Med. 57 (5): 341—7. PMC 1739951 . PMID 10769300. doi:10.1136/oem.57.5.341.
Bakst, R.; Merola, J. F.; Franks Jr, A. G.; Sanchez, M. (2008). „Raynaud's phenomenon: Pathogenesis and management”. Journal of the American Academy of Dermatology. 59 (4): 633—53. PMID 18656283. doi:10.1016/j.jaad.2008.06.004.
Thompson, A. E.; Pope, J. E. (2005). „Calcium channel blockers for primary Raynaud's phenomenon: A meta-analysis”. Rheumatology. 44 (2): 145—50. PMID 15546967. doi:10.1093/rheumatology/keh390.
Agah, R.; Bandi, V.; Guntupalli, K. K. (1997). „Angioedema: The role of ACE inhibitors and factors associated with poor clinical outcome”. Intensive Care Medicine. 23 (7): 793—6. PMID 9290997. S2CID 9530224. doi:10.1007/s001340050413.
Vleeming, W.; Van Amsterdam, J. G.; Stricker, B. H.; De Wildt, D. J. (1998). „ACE inhibitor-induced angioedema. Incidence, prevention and management”. Drug Saf. 18 (3): 171—88. PMID 9530537. S2CID 21040028. doi:10.2165/00002018-199818030-00003.
Bakst, R.; Merola, J. F.; Franks Jr, A. G.; Sanchez, M. (2008). „Raynaud's phenomenon: pathogenesis and management”. Journal of the American Academy of Dermatology. 59 (4): 633—53. PMID 18656283. doi:10.1016/j.jaad.2008.06.004.
Sheikh, A. Y.; Gibson, J. J.; Rollins, M. D.; Hopf, H. W.; Hussain, Z.; Hunt, T. K. (новембар 2000). „Effect of hyperoxia on vascular endothelial growth factor levels in a wound model”. Arch Surg. 135 (11): 1293—7. PMID 11074883. doi:10.1001/archsurg.135.11.1293.
Hunt, T. K.; Pai, M. P. (октобар 1972). „The effect of varying ambient oxygen tensions on wound metabolism and collagen synthesis”. Surg Gynecol Obstet. 135 (4): 561—7. PMID 5077722.
Guidot, D. M.; Repine, J. E.; Kitlowski, A. D.; Flores, S. C.; Nelson, S. K.; Wright, R. M.; McCord, J. M. (1995). „Mitochondrial respiration scavenges extramitochondrial superoxide anion via a nonenzymatic mechanism”. Invest. 96 (2): 1131—1136. PMC 185303 . PMID 7635949. doi:10.1172/JCI118100.
Knighton, D. R.; Silver, I. A.; Hunt, T. K. (август 1981). „Regulation of wound-healing angiogenesis-effect of oxygen gradients and inspired oxygen concentration”. Surgery. 90 (2): 262—70. PMID 6166996. .

oxfordjournals.org

rheumatology.oxfordjournals.org

Herrick AL (мај 2005). „Pathogenesis of Raynaud's phenomenon”. Rheumatology (Oxford). 44 (5): 587—96. PMID 15741200. doi:10.1093/rheumatology/keh552.
Coleiro, B.; Marshall, S. E.; Denton, C. P.; Howell, K.; Blann, A.; Welsh, K. I.; Black, C. M. (2001). „Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine”. Rheumatology. 40 (9): 1038—43. PMID 11561116. doi:10.1093/rheumatology/40.9.1038.
Maddison, P. (2002). „Prevention of vascular damage in scleroderma with angiotensin-converting enzyme (ACE) inhibition”. Rheumatology. 41 (9): 965—71. PMID 12209028. doi:10.1093/rheumatology/41.9.965.

pdfcoffee.com

Doc Doc. dr Aleksandar Milovanović BUKA I VIBRACIJE, nastavni sadržaj iz medicine rada, Medicinski fakultet u Beogradu [2], Приступљено 6. 5. 2024.

raynauds.org.uk

(језик: енглески) Reynaud’s and Scleroderma Association. Coping with Raynaud’s. [1] Архивирано на сајту Wayback Machine (20. март 2012), Приступљено 24. 4. 2013.

semanticscholar.org

api.semanticscholar.org

Goundry, B.; Bell, L.; Langtree, M.; Moorthy, A. (2012). „Diagnosis and management of Raynaud's phenomenon”. BMJ. 344: e289. PMID 22315243. S2CID 29237865. doi:10.1136/bmj.e289.
Block, J. A.; Sequeira, W. (2001). „Raynaud's phenomenon”. Lancet. 357 (9273): 2042—8. PMID 11438158. S2CID 27272970. doi:10.1016/S0140-6736(00)05118-7.
Jay, O.; Havenith, G. (2004). „Finger skin cooling on contact with cold materials: A comparison between male and female responses during short-term exposures”. European Journal of Applied Physiology. 91 (4): 373—381. PMID 14605896. S2CID 35852625. doi:10.1007/s00421-003-0986-0. .
Duprez, D. A. (јун 2006). „Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: A clinical review”. Journal of Hypertension. 24 (6): 983—91. PMID 16685192. S2CID 3085972. doi:10.1097/01.hjh.0000226182.60321.69.
Prescott, R. J.; Freemont, A. J.; Jones, C. J.; Hoyland, J.; Fielding, P. (1992). „Sequential dermal microvascular and perivascular changes in the development of scleroderma”. J Pathol. 166 (3): 255—63. PMID 1517881. S2CID 38077812. doi:10.1002/path.1711660307.
Agah, R.; Bandi, V.; Guntupalli, K. K. (1997). „Angioedema: The role of ACE inhibitors and factors associated with poor clinical outcome”. Intensive Care Medicine. 23 (7): 793—6. PMID 9290997. S2CID 9530224. doi:10.1007/s001340050413.
Vleeming, W.; Van Amsterdam, J. G.; Stricker, B. H.; De Wildt, D. J. (1998). „ACE inhibitor-induced angioedema. Incidence, prevention and management”. Drug Saf. 18 (3): 171—88. PMID 9530537. S2CID 21040028. doi:10.2165/00002018-199818030-00003.

thefreedictionary.com

medical-dictionary.thefreedictionary.com

„eponym (medical-dictionary)”. Архивирано из оригинала 21. 09. 2011. г. Приступљено 24. 4. 2013.
Sympathectomy - medical-dictionary

web.archive.org

„Raynaud's phenomenon- Definition”. Архивирано из оригинала 03. 04. 2009. г. Приступљено 24. 4. 2013.
„eponym (medical-dictionary)”. Архивирано из оригинала 21. 09. 2011. г. Приступљено 24. 4. 2013.
(језик: енглески) Reynaud’s and Scleroderma Association. Coping with Raynaud’s. [1] Архивирано на сајту Wayback Machine (20. март 2012), Приступљено 24. 4. 2013.
van Zwieten PA (1994). „Amlodipine: an overview of its pharmacodynamic and pharmacokinetic properties.”. Clin Cardiol. 17 (suppl III): III—3—III—6. . „Terapijski profil amlodipin maleata (Tenox®, Krka)” (PDF). Архивирано из оригинала (PDF) 21. 04. 2016. г. Приступљено 24. 4. 2013.
Lubbe, WF, and Hodge, JV: New Zealand Med J, 94 (691) 169–172, 1981. „Minipress Capsules (prazosin hydrochloride) For Oral Use” (PDF). Архивирано из оригинала (PDF) 19. 10. 2011. г. Приступљено 24. 4. 2013.
Davey, DA, and Dommisse, J: S.A. Med J, Oct. 4, 1980 (551–556). „Minipress Capsules (prazosin hydrochloride) For Oral Use” (PDF). Архивирано из оригинала (PDF) 19. 10. 2011. г. Приступљено 24. 4. 2013.

whfreeman.com

David L. Nelson; Michael M. Cox (2005). Principles of Biochemistry (IV изд.). New York: W. H. Freeman. ISBN 0-7167-4339-6.

whonamedit.com

„Who named it? - A. G. Maurice Raynaud”. Приступљено 24. 4. 2013.

wikipedia.org

en.wikipedia.org

Rajagopalan, Sanjay; Pfenninger, Dana; Kehrer, Christine; Chakrabarti, Anjan; Somers, Emily; Pavlic, Robert; Mukherjee, Debabrata; Brook, Robert; d'Alecy, Louis G.; Kaplan, Mariana J. (2003). „Increased asymmetric dimethylarginine and endothelin 1 levels in secondary Raynaud's phenomenon: Implications for vascular dysfunction and progression of disease”. Arthritis & Rheumatism. 48 (7): 1992—2000. PMID 12847693. doi:10.1002/art.11060. hdl:2027.42/34308.

worldcat.org

Matucci-Cerinic, M; Allanore, Y; Czirják, L; Tyndall, A; Müller-Ladner, U; Denton, C; Valentini, G; Distler, O; Fligelstone, K (2009-08-12). „The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy”. Annals of the Rheumatic Diseases. 68 (9): 1377—1380. ISSN 0003-4967. doi:10.1136/ard.2008.106302.
Avouac, J; Fransen, J; Walker, UA; Riccieri, V; Smith, V; Muller, C; Miniati, I; Tarner, IH; Randone, S Bellando (2010-11-15). „Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group”. Annals of the Rheumatic Diseases. 70 (3): 476—481. ISSN 0003-4967. doi:10.1136/ard.2010.136929.
Maricq, Hildegard Rand; Carwile LeRoy, E. (1973). „Patterns of finger capillary abnormalities in connective tissue disease by “wide‐field” microscopy”. Arthritis & Rheumatism. 16 (5): 619—628. ISSN 0004-3591. doi:10.1002/art.1780160506.
Cutolo, Maurizio; Sulli, Alberto; Smith, Vanessa (2013). „How to perform and interpret capillaroscopy”. Best Practice & Research Clinical Rheumatology. 27 (2): 237—248. ISSN 1521-6942. doi:10.1016/j.berh.2013.03.001.
Baron, Murray; Bell, Mary; Bookman, Arthur; Buchignani, Maura; Dunne, James; Hudson, Marie; Jerome, Dana; Johnson, Sindhu R.; Jones, Niall (2006-12-09). „Office capillaroscopy in systemic sclerosis”. Clinical Rheumatology. 26 (8): 1268—1274. ISSN 0770-3198. doi:10.1007/s10067-006-0489-6.
Maricq, Hildegard Rand; Carwile LeRoy, E. (1973). „Patterns of finger capillary abnormalities in connective tissue disease by “wide‐field” microscopy”. Arthritis & Rheumatism. 16 (5): 619—628. ISSN 0004-3591. doi:10.1002/art.1780160506.
Maverakis, Emanual; Patel, Forum; Kronenberg, Daniel G.; Chung, Lorinda; Fiorentino, David; Allanore, Yannick; Guiducci, Serena; Hesselstrand, Roger; Hummers, Laura K. (2014). „International consensus criteria for the diagnosis of Raynaud's phenomenon”. Journal of Autoimmunity. 48-49: 60—65. ISSN 0896-8411. doi:10.1016/j.jaut.2014.01.020.